Skip to main content
. 2007 Jul 4;7:25. doi: 10.1186/1471-230X-7-25

Table 4.

Base model ICER

QALYs Costs ICER
nsNSAID 10.1678 $10,096
Celecoxib 10.2982 $14,151
Net incremental 0.1304 $4,055 $31,097

ICER, incremental cost-effective ratio; QALY, quality-adjusted life year; nsNSAID, nonselective nonsteroidal anti-inflammatory drugs.